# Cyberonics, Inc. clinical trials: 22 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 22 trials with Cyberonics, Inc. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Cyberonics, Inc.: 22 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/cyberonics-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 22, 2017 | NCT03163030 | Autonomic Regulation Therapy in Heart Failure With Preserved Ejection Fraction | Cyberonics, Inc. | Not applicable | Completed | Congestive Heart Failure | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03163030) |
| September 10, 2015 | NCT02545582 | VITARIA Registry Study | Cyberonics, Inc. | Observational | Suspended | Congestive Heart Failure | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02545582) |
| March 11, 2015 | NCT02385526 | Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation | Cyberonics, Inc. | Observational | Completed | Epilepsy, Seizures | 67 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02385526) |
| May 3, 2013 | NCT01846741 | VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37) | Cyberonics, Inc. | Not applicable | Completed | Epilepsy | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01846741) |
| April 4, 2013 | NCT01823887 | Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) Study | Cyberonics, Inc. | Phase 1/2 | Completed | Congestive Heart Failure | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01823887) |
| June 25, 2012 | NCT01626599 | Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data | Cyberonics, Inc. | Not applicable | Completed | Epilepsy | 147 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01626599) |
| June 6, 2012 | NCT01612689 | 3-Dimensional Accelerometer Sub-Study | Cyberonics, Inc. | Not applicable | Completed | Epilepsy | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01612689) |
| December 6, 2011 | NCT01486056 | ECG Vector Determination | Cyberonics, Inc. | Observational | Completed | Epilepsy | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01486056) |
| December 5, 2011 | NCT01485016 | Physiological and Biomechanical Data Collection Study in Epilepsy Subjects | Cyberonics, Inc. | Observational | Completed | Epilepsy | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01485016) |
| March 30, 2011 | NCT01325623 | Seizure Detection and Automatic Magnet Mode Performance Study | Cyberonics, Inc. | Not applicable | Completed | Epilepsy | 31 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01325623) |
| January 21, 2011 | NCT01281293 | Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated | Cyberonics, Inc. | Observational | Completed | Epilepsy | 124 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01281293) |
| January 21, 2011 | NCT01281280 | PuLsE 2-Observational Long-Term Effectiveness Follow-Up Study of PuLsE 1 | Cyberonics, Inc. | Observational | Completed | Epilepsy | 81 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01281280) |
| December 29, 2010 | NCT01268007 | Heartbeat Sensitivity Calibration Using the ECG Accessory | Cyberonics, Inc. | Observational | Completed | ECG Comparisons in Normal Healthy Subject | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01268007) |
| October 5, 2010 | NCT01214707 | Heart Rate Changes During Normal Activity, Exercise, and Seizures in Subjects With Epilepsy | Cyberonics, Inc. | Observational | Completed | Epilepsy | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01214707) |
| September 16, 2010 | NCT01202682 | Heart Rate Changes During Normal Activity, Exercise, and Sleep in Normal Healthy Subjects With and Without Epilepsy | Cyberonics, Inc. | Observational | Completed | Healthy, Exercise | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01202682) |
| September 16, 2010 | NCT01202669 | Heart Rate Changes in Subjects With Epilepsy | Cyberonics, Inc. | Observational | Completed | Epilepsy | 98 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01202669) |
| May 6, 2010 | NCT01118455 | Trial to Assess Vagus Nerve Stimulation Therapy vs. Anti-Epileptic Drug (AED) Treatment in Children With Refractory Seizures | Cyberonics, Inc. | Phase 4 | Terminated | Epilepsy | 134 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01118455) |
| September 24, 2007 | NCT00533832 | Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD) | Cyberonics, Inc. | Not applicable | Completed | Major Depressive Disorder | 266 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00533832) |
| August 29, 2007 | NCT00522418 | Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy Patients | Cyberonics, Inc. | Phase 4 | Terminated | Epilepsy, Partial Epilepsy | 122 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00522418) |
| May 3, 2006 | NCT00320372 | Treatment-Resistant Depression Registry | Cyberonics, Inc. | Observational | Completed | Major Depressive Disorder | 795 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00320372) |
| March 22, 2006 | NCT00305565 | Study Comparing Outcomes for Patients With Treatment Resistant Depression Who Receive VNS Therapy at Different Doses | Cyberonics, Inc. | Phase 4 | Completed | Depression | 331 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00305565) |
| September 22, 2005 | NCT00215215 | Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures | Cyberonics, Inc. | Phase 4 | Terminated | Epilepsies, Partial | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00215215) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1/2 | 1 |
| Phase 4 | 4 |
| Not applicable | 6 |
| Observational | 11 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 18 |
| Terminated | 3 |
| Suspended | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Epilepsy | 13 |
| Heart Failure | 3 |
| Epilepsies, Partial | 2 |
| Seizures | 2 |
| Depressive Disorder, Major | 2 |
| Depression | 2 |
| Motor Activity | 1 |
| Depressive Disorder, Treatment-Resistant | 1 |
| Bipolar Disorder | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Lebanese restaurants in the United States](https://specstream.ai/data/businesses/lebanese-restaurants/united-states)
- [Road contractors in the United States](https://specstream.ai/data/businesses/road-contractors/united-states)
- [Appraisers in the United States](https://specstream.ai/data/businesses/appraisers/united-states)
- [Dentistry schools in the United States](https://specstream.ai/data/businesses/dentistry-schools/united-states)
- [Internet service providers in the United States](https://specstream.ai/data/businesses/internet-service-providers/united-states)
- [Property management companies in the United States](https://specstream.ai/data/businesses/property-management-companies/united-states)
